Clinical Trial Update: Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 study comparing the pharmacodynamics and pharmacokinetics of insulin aspart versus human insulin in elderly patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Human insulin (insulin regular (human insulin))
• Insulin aspart (NovoLog) (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED